Ratings changes for Repare Therapeutics, 8X8, Costco Wholesale, NovoCure, Tempus AI, Microsoft, Ark Restaurants and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
Is Your Portfolio Ready for Post-Election Uncertainty? (ad)
Now is the time to consider a time-tested asset favored by conservative investors for navigating market volatility and building long-term security. Whether the results lean toward continuity or change, this asset remains a stable cornerstone for safeguarding wealth and driving growth.
By following the link, you’re choosing to opt in to receive insightful updates from Wealth Creation Investing + 2 free bonus subscriptions! Your privacy is important to us. You can unsubscribe anytime. See our privacy policy for details.
Amazon.com (NASDAQ:AMZN) had its price target raised by analysts at Robert W. Baird () from $220.00 to $260.00. They now have an “outperform” rating on the stock. This represents a 13.6% upside from the current price of $228.97.
Alphabet Inc. (NASDAQ:GOOGL) declared a quarterly dividend on Monday, October 28th. Shareholders of record on Monday, December 9th will be paid a dividend of 0.20 per share by the information services provider on Monday, December 16th. This represents a $0.80 annualized dividend and a yield of 0.42%. The ex-dividend date is Monday, December 9th.
Meta Platforms, Inc. (NASDAQ:META) announced a quarterly dividend on Thursday, December 5th. Stockholders of record on Monday, December 16th will be given a dividend of 0.50 per share by the social networking company on Friday, December 27th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date of this dividend is Monday, December 16th.
insider Jennifer Newstead sold 905 shares of the stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $618.00, for a total value of $559,290.00. Following the completion of the transaction, the insider now owns 35,630 shares of the company’s stock, valued at $22,019,340. This represents a 2.48 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Microsoft (NASDAQ:MSFT) had its price target raised by analysts at Mizuho () from $480.00 to $510.00. They now have an “outperform” rating on the stock. This represents a 13.4% upside from the current price of $449.56.
Amplitude (NASDAQ:AMPL) was upgraded by analysts at KeyCorp from a “sector weight” rating to an “overweight” rating. They now have a $15.00 price target on the stock. This represents a 28.0% upside from the current price of $11.72.
Cardinal Health (NYSE:CAH) was upgraded by analysts at Wells Fargo & Company from an “underweight” rating to an “equal weight” rating. They now have a $127.00 price target on the stock, up previously from $101.00. This represents a 8.0% upside from the current price of $117.58.
Century Communities (NYSE:CCS) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating. They now have a $97.00 price target on the stock, down previously from $110.00. This represents a 16.0% upside from the current price of $83.62.
Ciena (NYSE:CIEN) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $95.00 price target on the stock, up previously from $70.00. This represents a 7.3% upside from the current price of $88.55.
Centene (NYSE:CNC) was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating. They now have a $80.00 price target on the stock, up previously from $79.00. This represents a 35.7% upside from the current price of $58.97.
Salesforce (NYSE:CRM) was upgraded by analysts at KeyCorp from a “sector weight” rating to an “overweight” rating. They now have a $440.00 price target on the stock. This represents a 22.6% upside from the current price of $359.00.
Danaher (NYSE:DHR) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $290.00 price target on the stock. This represents a 24.5% upside from the current price of $233.02.
General Mills (NYSE:GIS) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $80.00 price target on the stock, up previously from $78.00. This represents a 20.0% upside from the current price of $66.66.
Gaming and Leisure Properties (NASDAQ:GLPI) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $54.00 price target on the stock, up previously from $49.00. This represents a 8.3% upside from the current price of $49.84.
Norwegian Cruise Line (NYSE:NCLH) was upgraded by analysts at Barclays PLC from an “equal weight” rating to an “overweight” rating. They now have a $32.00 price target on the stock, up previously from $28.00. This represents a 19.3% upside from the current price of $26.83.
PENN Entertainment (NASDAQ:PENN) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $27.00 price target on the stock, up previously from $19.00. This represents a 30.2% upside from the current price of $20.73.
PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $67.00 price target on the stock, up previously from $45.00. This represents a 38.9% upside from the current price of $48.24.
Patterson-UTI Energy (NASDAQ:PTEN) was upgraded by analysts at The Goldman Sachs Group, Inc. from a “neutral” rating to a “buy” rating. They now have a $10.00 price target on the stock, down previously from $11.00. This represents a 30.0% upside from the current price of $7.69.
PayPal (NASDAQ:PYPL) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating. They now have a $107.00 price target on the stock. This represents a 18.5% upside from the current price of $90.31.
Robert Half (NYSE:RHI) was upgraded by analysts at Truist Financial Co. from a “hold” rating to a “buy” rating. They now have a $90.00 price target on the stock, up previously from $62.00. This represents a 17.1% upside from the current price of $76.85.
Revvity (NYSE:RVTY) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $138.00 price target on the stock. This represents a 21.5% upside from the current price of $113.61.
Sangamo Therapeutics (NASDAQ:SGMO) was upgraded by analysts at Truist Financial Co. from a “hold” rating to a “buy” rating. They now have a $7.00 price target on the stock. This represents a 233.7% upside from the current price of $2.10.
Block (NYSE:SQ) was upgraded by analysts at Monness Crespi & Hardt from a “neutral” rating to a “buy” rating. They now have a $115.00 price target on the stock. This represents a 21.7% upside from the current price of $94.49.
Sempra (NYSE:SRE) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $98.00 price target on the stock, up previously from $85.00. This represents a 10.2% upside from the current price of $88.91.
TaskUs (NASDAQ:TASK) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $21.00 price target on the stock, up previously from $18.00. This represents a 18.1% upside from the current price of $17.78.
Upstart (NASDAQ:UPST) was upgraded by analysts at Needham & Company LLC from a “hold” rating to a “buy” rating. They now have a $100.00 price target on the stock. This represents a 19.1% upside from the current price of $83.93.
Marriott Vacations Worldwide (NYSE:VAC) was upgraded by analysts at Barclays PLC from an “equal weight” rating to an “overweight” rating. They now have a $116.00 price target on the stock, up previously from $97.00. This represents a 22.3% upside from the current price of $94.84.
Viper Energy (NASDAQ:VNOM) was upgraded by analysts at KeyCorp from a “sector weight” rating to an “overweight” rating. They now have a $62.00 price target on the stock. This represents a 21.2% upside from the current price of $51.17.
Audentes Therapeutics (NASDAQ:BOLD) was downgraded by analysts at Guggenheim from a “buy” rating to a “neutral” rating.The current price is $2.95.
D.R. Horton (NYSE:DHI) was downgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating. They now have a $156.00 price target on the stock, down previously from $188.00. This represents a 4.5% upside from the current price of $149.23.
Editas Medicine (NASDAQ:EDIT) was downgraded by analysts at Truist Financial Co. from a “buy” rating to a “hold” rating.The current price is $1.56.
Editas Medicine (NASDAQ:EDIT) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $3.00 price target on the stock, down previously from $11.00. This represents a 92.9% upside from the current price of $1.56.
8X8 (NASDAQ:EGHT) was downgraded by analysts at Mizuho from a “neutral” rating to an “underperform” rating. They now have a $2.50 price target on the stock, down previously from $2.75. This represents a 7.1% downside from the current price of $2.69.
Immuneering (NASDAQ:IMRX) was downgraded by analysts at Morgan Stanley from an “equal weight” rating to an “underweight” rating.The current price is $1.68.
monday.com (NASDAQ:MNDY) was downgraded by analysts at KeyCorp from an “overweight” rating to a “sector weight” rating.The current price is $279.79.
ServiceNow (NYSE:NOW) was downgraded by analysts at KeyCorp from an “overweight” rating to a “sector weight” rating.The current price is $1,135.48.
TELUS (NYSE:TU) (TSE:T) was downgraded by analysts at National Bank Financial from an “outperform” rating to a “sector perform” rating.The current price is $14.48.
Weatherford International (NASDAQ:WFRD) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $98.00 price target on the stock, down previously from $132.00. This represents a 27.1% upside from the current price of $77.11.
ZoomInfo Technologies (NASDAQ:ZI) was downgraded by analysts at KeyCorp from a “sector weight” rating to an “underweight” rating.The current price is $10.31.
Advance Auto Parts (NYSE:AAP) is now covered by analysts at BMO Capital Markets. They set a “market perform” rating and a $45.00 price target on the stock. This represents a 4.4% upside from the current price of $43.12.
American Eagle Outfitters (NYSE:AEO) is now covered by analysts at Raymond James. They set a “market perform” rating on the stock.The current price is $17.18.
AES (NYSE:AES) is now covered by analysts at HSBC Holdings plc. They set a “buy” rating and a $17.00 price target on the stock. This represents a 27.0% upside from the current price of $13.39.
Atmos Energy (NYSE:ATO) is now covered by analysts at Bank of America Co.. They set a “buy” rating and a $156.00 price target on the stock. This represents a 11.5% upside from the current price of $139.97.
AutoZone (NYSE:AZO) is now covered by analysts at BMO Capital Markets. They set an “outperform” rating and a $3,700.00 price target on the stock. This represents a 9.5% upside from the current price of $3,378.00.
Benitec Biopharma (NASDAQ:BNTC) is now covered by analysts at Robert W. Baird. They set an “outperform” rating and a $30.00 price target on the stock. This represents a 142.7% upside from the current price of $12.36.
Cidara Therapeutics (NASDAQ:CDTX) is now covered by analysts at Royal Bank of Canada. They set an “outperform” rating and a $34.00 price target on the stock. This represents a 45.2% upside from the current price of $23.41.
Coty (NYSE:COTY) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $9.00 price target on the stock. This represents a 22.1% upside from the current price of $7.37.
Canadian Solar (NASDAQ:CSIQ) is now covered by analysts at Mizuho. They set an “outperform” rating and a $20.00 price target on the stock. This represents a 58.2% upside from the current price of $12.64.
Dyne Therapeutics (NASDAQ:DYN) is now covered by analysts at Robert W. Baird. They set an “outperform” rating and a $46.00 price target on the stock. This represents a 80.7% upside from the current price of $25.46.
e.l.f. Beauty (NYSE:ELF) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $165.00 price target on the stock. This represents a 21.8% upside from the current price of $135.52.
Enliven Therapeutics (NASDAQ:ELVN) is now covered by analysts at BTIG Research. They set a “buy” rating and a $42.00 price target on the stock. This represents a 83.3% upside from the current price of $22.91.
TechnipFMC (NYSE:FTI) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $38.00 price target on the stock. This represents a 23.0% upside from the current price of $30.90.
Group 1 Automotive (NYSE:GPI) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $500.00 price target on the stock. This represents a 17.6% upside from the current price of $425.00.
Hologic (NASDAQ:HOLX) is now covered by analysts at Wolfe Research. They set a “peer perform” rating on the stock.The current price is $74.42.
MKS Instruments (NASDAQ:MKSI) is now covered by analysts at JPMorgan Chase & Co.. They set an “overweight” rating and a $145.00 price target on the stock. This represents a 27.1% upside from the current price of $114.12.
Oddity Tech (NASDAQ:ODD) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $48.00 price target on the stock. This represents a 0.2% upside from the current price of $47.89.
ONE Gas (NYSE:OGS) is now covered by analysts at Bank of America Co.. They set a “buy” rating and a $77.00 price target on the stock. This represents a 9.9% upside from the current price of $70.07.
O’Reilly Automotive (NASDAQ:ORLY) is now covered by analysts at BMO Capital Markets. They set an “outperform” rating and a $1,400.00 price target on the stock. This represents a 9.8% upside from the current price of $1,274.86.
Provident Financial Services (NYSE:PFS) is now covered by analysts at Hovde Group. They set an “outperform” rating and a $25.00 price target on the stock. This represents a 24.4% upside from the current price of $20.10.
ResMed (NYSE:RMD) is now covered by analysts at Stifel Nicolaus. They set a “hold” rating and a $250.00 price target on the stock. This represents a 4.7% upside from the current price of $238.68.
Solid Biosciences (NASDAQ:SLDB) is now covered by analysts at Wedbush. They set an “outperform” rating and a $16.00 price target on the stock. This represents a 230.6% upside from the current price of $4.84.
Shanda Interactive Entertainment (NASDAQ:SNDA) is now covered by analysts at Morgan Stanley. They set an “equal weight” rating and a $25.00 price target on the stock. This represents a 4.5% upside from the current price of $23.92.
Spire (NYSE:SR) is now covered by analysts at Bank of America Co.. They set a “neutral” rating and a $70.00 price target on the stock. This represents a 4.3% upside from the current price of $67.11.
Stevanato Group (NYSE:STVN) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $28.00 price target on the stock.
Tempus AI (NASDAQ:TEM) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $60.00 price target on the stock. This represents a 39.6% upside from the current price of $42.99.
THOR Industries (NYSE:THO) is now covered by analysts at Bank of America Co.. They set a “neutral” rating and a $120.00 price target on the stock. This represents a 15.3% upside from the current price of $104.11.
Titan International (NYSE:TWI) is now covered by analysts at DA Davidson. They set a “buy” rating and a $11.00 price target on the stock. This represents a 39.4% upside from the current price of $7.89.
Twist Bioscience (NASDAQ:TWST) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $60.00 price target on the stock. This represents a 26.9% upside from the current price of $47.28.
West Pharmaceutical Services (NYSE:WST) is now covered by analysts at Wolfe Research. They set a “peer perform” rating on the stock.The current price is $328.26.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.